Literature DB >> 20599586

A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report.

Takashi Kudo1, Tetsuya Kushikata, Mihoko Kudo, Tsuyoshi Kudo, Kazuyoshi Hirota.   

Abstract

Neuropathic pain models are classified as central and peripheral pain models. Although various peripheral neuropathic pain models are established, central pain models are based only on spinal cord injury. DSP-4 is a competitive inhibitor of norepinephrine uptake that selectively degenerates the locus coeruleus (LC)-noradrenergic neurons projection to the cerebral cortex and hippocampus. In the present study, we have tested whether lesion of LC-noradrenergic neurons by ip DSP-4 (0, 10, 30, 50 mg/kg, n=7 each) could provide a new central neuropathic pain model in rats using a hot-plate and tail-flick tests. DSP-4 significantly reduced the hot-plate latency and norepinephrine contents especially in the coerulean regions. However, DSP-4 did not change tail-flick latency. There are significant correlations of the latency in the hot-plate test with norepinephrine contents in the cerebral cortex (r=0.432, p=0.022), the hippocampus (r=0.465, p=0.013) and the pons (r=0.400, p=0.035) but not with those in the hypothalamus and the spinal cord. As response to hot-plate and tail-flick implies supra-spinal process and spinal reflex, respectively, central neuropathic pain may be facilitated by DSP-4 depleting LC-noradrenergic neurons although the present data are preliminary. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599586     DOI: 10.1016/j.neulet.2010.06.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

2.  Central noradrenergic activity affects analgesic effect of Neuropeptide S.

Authors:  Kei Jinushi; Tetsuya Kushikata; Takashi Kudo; Girolamo Calo; Remo Guerrini; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2017-11-11       Impact factor: 2.078

3.  The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João Batista Teixeira da Rocha
Journal:  Adv Neurotoxicol       Date:  2017-09-01

4.  Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.

Authors:  Lei-Fang Cao; Xiao-Yan Peng; Ya Huang; Bing Wang; Feng-Ming Zhou; Ruo-Xiao Cheng; Li-Hua Chen; Wei-Feng Luo; Tong Liu
Journal:  Neural Plast       Date:  2016-09-26       Impact factor: 3.599

5.  Anti-pain and anti-inflammation like effects of Neptune krill oil and fish oil against carrageenan induced inflammation in mice models: Current statues and pilot study.

Authors:  Parastoo Mojtahed Zadeh-Ardabili; Sima Kianpour Rad
Journal:  Biotechnol Rep (Amst)       Date:  2019-04-18

6.  Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.

Authors:  Jun Kinoshita; Yukari Takahashi; Ayako M Watabe; Kazunori Utsunomiya; Fusao Kato
Journal:  Mol Pain       Date:  2013-11-27       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.